Literature DB >> 32551759

COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine.

Brandy F Henry1, Amar D Mandavia2, Margaret M Paschen-Wolff3, Timothy Hunt1, Jennifer L Humensky3, Elwin Wu1, Harold A Pincus4, Edward V Nunes3, Frances R Levin3, Nabila El-Bassel1.   

Abstract

The United States is facing both the coronavirus disease 2019 (COVID-19) pandemic and an ongoing epidemic of opioid overdose. Opioid use disorder is associated with other mental health problems, trauma, and social and health disparities. While the United States has acted to improve access to treatment for mental health and opioid use, research will be needed to understand the effectiveness of new policies in the context of COVID-19. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh：

Year:  2020        PMID： 32551759      PMCID： PMC7583654          DOI： 10.1037/tra0000660

Source DB:  PubMed          Journal:  Psychol Trauma        ISSN： 1942-969X


  9 in total

1.  Digital approaches for mental health in the age of covid-19.

Authors:  Bernard P Chang; Ronald C Kessler; Harold A Pincus; Matthew K Nock
Journal:  BMJ       Date:  2020-06-29

2.  Differences in the determinants of posttraumatic stress disorder and depression after a mass traumatic event.

Authors:  Melissa Tracy; Fran H Norris; Sandro Galea
Journal:  Depress Anxiety       Date:  2011-05-26       Impact factor: 6.505

3.  Improving Access to Effective Care for People With Mental Health and Substance Use Disorders.

Authors:  James Knickman; Ranga Krishnan; Harold Pincus
Journal:  JAMA       Date:  2016-10-25       Impact factor: 56.272

4.  The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention.

Authors:  Sandro Galea; Raina M Merchant; Nicole Lurie
Journal:  JAMA Intern Med       Date:  2020-06-01       Impact factor: 21.873

5.  The Effects of Co-Occurring Interpersonal Trauma and Gender on Opioid Use and Misuse.

Authors:  Jessica Roberts Williams; Susan Girdler; Weston Williams; Martha Grace Cromeens
Journal:  J Interpers Violence       Date:  2020-02-13

6.  Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting.

Authors:  Janna Ataiants; Alexis M Roth; Silvana Mazzella; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2020-02-18

7.  COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better.

Authors:  Yuhua Bao; Arthur Robin Williams; Bruce R Schackman
Journal:  Psychiatr Serv       Date:  2020-08-12       Impact factor: 3.084

8.  Responding to Healthcare Disparities and Challenges With Access to Care During COVID-19.

Authors:  Ana Núñez; Maria Madison; Renata Schiavo; Ronit Elk; Holly G Prigerson
Journal:  Health Equity       Date:  2020-04-14

9.  Collision of the COVID-19 and Addiction Epidemics.

Authors:  Nora D Volkow
Journal:  Ann Intern Med       Date:  2020-04-02       Impact factor: 25.391
  9 in total
  15 in total

1.  Sex, gender, and the opioid epidemic: Crucial implications for acute care.

Authors:  Lauren A Walter; Savannah Bunnell; Kathryn Wiesendanger; Alyson J McGregor
Journal:  AEM Educ Train       Date:  2022-06-23

2.  Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.

Authors:  Christopher M Jones; Mamadou M Diallo; Meena Vythilingam; Joshua G Schier; Matthew Eisenstat; Wilson M Compton
Journal:  Drug Alcohol Depend       Date:  2021-05-23       Impact factor: 4.852

3.  Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.

Authors:  Christopher M Jones; Gery P Guy; Amy Board
Journal:  Drug Alcohol Depend       Date:  2021-01-06       Impact factor: 4.852

4.  Shifting Pathways of Stimulant Use Among Individuals With Opioid Use Disorder: A Retrospective Analysis of the Last Thirty Years.

Authors:  Matthew S Ellis; Zachary A Kasper; Stephen Scroggins
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

5.  The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services.

Authors:  Yesenia Aponte-Melendez; Pedro Mateu-Gelabert; Chunki Fong; Benjamin Eckhardt; Shashi Kapadia; Kristen Marks
Journal:  Harm Reduct J       Date:  2021-11-24

6.  COVID-19 economic impact payments and opioid overdose deaths.

Authors:  Jon E Sprague; Arthur B Yeh; Qizhen Lan; Jamie Vieson; Maggie McCorkle
Journal:  Int J Drug Policy       Date:  2022-01-31

7.  The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.

Authors:  Joe Schofield; Joshua Dumbrell; Catriona Matheson; Tessa Parkes; Angus Bancroft
Journal:  BMC Public Health       Date:  2022-03-15       Impact factor: 3.295

8.  Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.

Authors:  Colleen B Mistler; Matthew C Sullivan; Michael M Copenhaver; Jaimie P Meyer; Alexis M Roth; Sheela V Shenoi; E Jennifer Edelman; Jeffrey A Wickersham; Roman Shrestha
Journal:  J Subst Abuse Treat       Date:  2021-04-08

9.  Use of a Research as Intervention Approach to Explore Telebehavioral Health Services During the COVID-19 Pandemic in Southeastern Idaho.

Authors:  Diana C Schow; Ann Thomson; Wilson T Trusty; Laurel Buchi-Fotre
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

Review 10.  Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework.

Authors:  Tribesty Nguyen; Jane A Buxton
Journal:  Int J Drug Policy       Date:  2021-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.